Hydrogen is increasingly seen as an important element of future ‘energy landscape’ and while its production through renewable means offers great promise, it is apparent that such sources may not be sufficient to meet expected demands in the short to medium term. It is important, therefore, to consider how this ‘gap’ may be bridged most responsibly by the efficient use of non-renewable resources, writes UCD's Keelan Glennane.

As the market for novel biopharmaceutical products grow, so does the demand for productive, reliable manufacturing processes which can be rapidly developed at a large scale. Chromatography, a foundational process in pharmaceutical manufacturing has seen increased process efficiency and productivity with the extension from traditional batch to continuous counter-current operation, writes Niamh O'Connell.

The Defence Forces' Chief Officer Instructor of the Ordnance School, who holds a master's in ordnance mechanical engineering, writes about the DISARM (Disablement In Situ Alternative Remote Mechanisms) project, which offers a suite of applied engineering solutions designed to combat an array of strategically complex explosive engineering problems.

The interest in fullerenes lies in their unique energy levels and high electron affinity which makes these molecules promising candidates for biological applications such as carriers for drug and gene therapy, or pharmaceutical applications such as being used as carriers for drug delivery and increasing the acceptance of artificial implants, writes Carl Pichon.

From arsenic pills to cancer-inducing moisturisers, cosmetics have been harming humans for centuries.

Since many drugs cannot be delivered efficiently due to various obstacles such as low aqueous solubility and short half-life, designing a delivery system that makes the therapeutic agents show their highest possible healing process capacity is imperative, writes Ciara O'Sullivan.